Neurofibromastosis type II (NF2) is a condition that may result in bilateral acoustic neuromas. The tumors and their removal may cause profound bilateral deafness. Because the auditory nerve is compromised, people with NF2 are unable to receive a cochlear implant to restore a sensation of hearing. Electrical stimulation of the auditory pathway can provide hearing in such people. This is possible by means of an auditory brainstem implant (ABI). This article focuses on the MED-EL high-rate multichannel ABI system. The system consists of the implanted and external components. Appropriate placement of the ABI is dependent on electrical auditory brainstem response testing performed intra-operatively. Data on a group of European patients implante...
Auditory brainstem implants (ABIs) are currently indicated for patients older than 12 years with neu...
AbstractNeurofibromatosis 2 (NF2) is an autosomal dominant disease in which hearing loss is predomin...
PURPOSE OF REVIEW: Neurofibromatosis type 2 (NF2) produces benign Schwann cell tumors on many crania...
Objective: Neurofibromatosis Type 2 (NF2) patients have multiple central nervous system tumors and, ...
Abstract PURPOSE OF REVIEW: Neurofibromatosis type 2 (NF2) produces benign Schwann cell tumors on m...
This is a publisher’s version of an article published in The Australian Journal of Otolaryngology 19...
Auditory brainstem implantation (ABI) is the only solution to restore hearing when cochlear nerves a...
Summary: The development of cochlear implantation has al-lowed the majority of patients deafened aft...
HYPOTHESIS: Electrical stimulation of the inferior colliculus in the midbrain can provide a safe and...
ABSTRACT: Multichannel auditory brainstem implants (ABI) are currently indicated for patients with n...
SummaryAuditory Brainstem Implants were developed to partially restore the hearing capabilities of p...
This prospective study aimed to determine speech understanding in neurofibromatosis type II (NF2) pa...
ABIs activate neurons in the cochlear nucleus to recreate hearing sensations in people who have beco...
OBJECTIVE: To assess the potential benefit of the MXM auditory brainstem implant for patients with n...
Summary: Auditory Brainstem Implants were developed to partially restore the hearing capabilities of...
Auditory brainstem implants (ABIs) are currently indicated for patients older than 12 years with neu...
AbstractNeurofibromatosis 2 (NF2) is an autosomal dominant disease in which hearing loss is predomin...
PURPOSE OF REVIEW: Neurofibromatosis type 2 (NF2) produces benign Schwann cell tumors on many crania...
Objective: Neurofibromatosis Type 2 (NF2) patients have multiple central nervous system tumors and, ...
Abstract PURPOSE OF REVIEW: Neurofibromatosis type 2 (NF2) produces benign Schwann cell tumors on m...
This is a publisher’s version of an article published in The Australian Journal of Otolaryngology 19...
Auditory brainstem implantation (ABI) is the only solution to restore hearing when cochlear nerves a...
Summary: The development of cochlear implantation has al-lowed the majority of patients deafened aft...
HYPOTHESIS: Electrical stimulation of the inferior colliculus in the midbrain can provide a safe and...
ABSTRACT: Multichannel auditory brainstem implants (ABI) are currently indicated for patients with n...
SummaryAuditory Brainstem Implants were developed to partially restore the hearing capabilities of p...
This prospective study aimed to determine speech understanding in neurofibromatosis type II (NF2) pa...
ABIs activate neurons in the cochlear nucleus to recreate hearing sensations in people who have beco...
OBJECTIVE: To assess the potential benefit of the MXM auditory brainstem implant for patients with n...
Summary: Auditory Brainstem Implants were developed to partially restore the hearing capabilities of...
Auditory brainstem implants (ABIs) are currently indicated for patients older than 12 years with neu...
AbstractNeurofibromatosis 2 (NF2) is an autosomal dominant disease in which hearing loss is predomin...
PURPOSE OF REVIEW: Neurofibromatosis type 2 (NF2) produces benign Schwann cell tumors on many crania...